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Abstract
Background: T1D and AITD are autoimmune disorders commonly occurring in the same family and even in the
same individual. The genetic contribution to these disorders is complex making uncovering of susceptibility genes very
challenging. The general aim of this study was to identify loci and genes contributing to T1D/AITD susceptibility. Our
strategy was to perform linkage and association studies in the relatively genetically homogenous population
of northern Sweden. We performed a GWLS to find genomic regions linked to T1D/AITD in families from
northern Sweden and we performed an association study in the families to test for association between T1D/
AITD and variants in previously published candidate genes as well as a novel candidate gene, CD247.
Methods: DNA prepared from 459 individuals was used to perform a linkage and an association study. The
ABI PRISM Linkage Mapping Set v2.5MD10 was employed for an initial 10-cM GWLS, and additional markers
were added for fine mapping. Merlin was used for linkage calculations. For the association analysis, a GoldenGate
Custom Panel from Illumina containing 79 SNPs of interest was used and FBAT was used for association calculations.
Results: Our study revealed linkage to two previously identified chromosomal regions, 4q25 and 6p22, as well as to a
novel chromosomal region, 1q23. The association study replicated association to PTPN22, HLA-DRB1, INS, IFIH1, CTLA4
and C12orf30. Evidence in favor of association was also found for SNPs in the novel susceptibility gene CD247.
Conclusions: Several risk loci for T1D/AITD identified in published association studies were replicated in a family
material, of modest size, from northern Sweden. This provides evidence that these loci confer disease susceptibility in
this population and emphasizes that small to intermediate sized family studies in this population can be used in
a cost-effective manner for the search of genes involved in complex diseases. The linkage study revealed a chromosomal
region in which a novel T1D/AITD susceptibility gene, CD247, is located. The association study showed association
between T1D/AITD and several variants in this gene. These results suggests that common susceptibility genes act in
concert with variants of CD247 to generate genetic risk for T1D/AITD in this population.
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Background
Type 1 diabetes mellitus (T1D) and autoimmune thyroid
disease (AITD) are autoimmune disorders under complex
genetic control [1]. There is a well-known association
between T1D and AITD, and both diseases often occur in
the same family and even in the same individual,
suggesting common genetic causes [1–4]. Several
genome-wide linkage scans (GWLS) have been performed
to search for genes contributing to T1D [5–10], but to
date, no GWLS has been performed on the population of
northern Sweden. An internal expansion of the northern
Swedish population, together with a low frequency of
immigration and a high frequency of consanguineous
marriages has resulted in a relatively genetically homoge-
neous population [11–13]. This genetic composition
coupled with other factors, such as the Swedish healthcare
system and detailed church records, have enabled the
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successful use of this population in genetic studies of com-
plex diseases, such as T1D [14, 15], type 2 diabetes [16, 17]
and stroke [18]. Genome-wide association (GWA) studies
have revealed several risk factor genes/loci for T1D, AITD
and a number of other diseases [19–25]. These studies have
found convincing evidence of associations of several loci
with T1D: HLA class II genes on chromosome 6p21, INS
on 11p15, CTLA4 on 2q33, PTPN22 on 1p13, the IL2Rα
region on 10p15 and the IFIH1 region on 2q24. Multiple
novel chromosomal regions, including 12q13, 12q24, 16p13
and 18p11, have been associated with T1D in both family-
based studies and case-control cohorts [19, 21, 23, 26].
Several of the identified risk genes are immunoregulatory
in nature, and many of these genes and/or associated
biological pathways have also been observed to overlap with
findings from animal models of T1D, notably the non-
obese diabetic (NOD) mouse model.
Both T1D and AITD develop through a process medi-
ated by T lymphocytes [1] and signaling through the T cell
receptor (TCR)/CD3 complex is required for the activation
of T cells. The CD3 complex consists of two CD3ε, one
CD3γ, one CD3δ and two CD3ζ subunits. Phosphorylation
of immunoreceptor tyrosine-based activation motifs
(ITAMs) in the CD3 complex is one of the earliest detect-
able events occurring after TCR engagement [27, 28].
Several of the genes associated to T1D and/or AITD, such
as PTPN22, CTLA4 and IL2/IL2RA are important for T cell
activation, regulation and function [29–32].
In this study, linkage and association analyses of multi-
plex families from northern Sweden have been employed
to find genetic regions and variants contributing to T1D/
AITD in the families. We report linkage to T1D/AITD for
three chromosomal region and we replicate the previously
reported association for T1D/AITD with single nucleotide
polymorphisms (SNPs) in PTPN22, HLA-DRB1, INS,
IFIH1, CTLA4 and C12orf30 [21, 23, 24, 33, 34]. We also




The initial 10-centimorgan (cM) GWLS included a total
of 42 families with 184 family members (54 patients with
T1D, 48 patients with AITD, 12 patients with both disor-
ders and 70 unaffected family members) from northern
Sweden. Population-based registers, the autoimmune
disease register at Sunderby Hospital and the Swedish
childhood diabetes registry [35] were used to identify T1D
or AITD probands below the age of 50. First-degree rela-
tives with T1D or AITD were then identified, and diabetes
diagnoses were confirmed by examining the medical
records of both probands and relatives. Genotyping of
regions with an initial logarithm of odds (LOD) score
higher than 1.5 was further performed in 275 individuals
(69 patients with T1D, 62 patients with AITD, 8 patients
with both disorders 136 unaffected family members) from
an additional 55 families. In a family-based association
study, all 459 individuals from the 97 families were geno-
typed and analyzed. This study was conducted with the
approval of the regional ethical review board, and
informed consent was obtained from all participants.
Clinical characteristics of the study material can be found
in Additional file 1: Tables S1 and S2.
DNA extraction
Genomic DNA was prepared from buffy coat samples
using the FlexiGene DNA Kit (Qiagen, Venlo, the
Netherlands). DNA extraction was performed according
to the manufacturer’s instructions.
Genome-wide scan
An ABI linkage panel set with an average spacing of
10 cM (ABI PRISM Linkage Mapping Set v2.5MD10, Ap-
plied Biosystems, Foster City, CA, USA) was used for the
initial 10-cM GWLS. PCR products were analyzed on an
ABI PRISM 3730 DNA Sequencer, and genotypes were
analyzed using GeneMapper v3.7 (Applied Biosystems,
Foster City, CA, USA). The largest gap in the initial
GWLS was 14.7 cM. Additional markers from the ABI
PRISM Linkage Mapping 5-cM Set, and markers ordered
from DNA Technology (Aarhus, Denmark) were typed on
chromosomes 1, 4 and 6 in the regions with an initial
LOD score higher than 1.5.
SNP genotyping
A GoldenGate Custom Panel containing 79 SNPs of inter-
est (Additional file 1: Table S3) was purchased from
Illumina (San Diego, CA), and genotyping was performed
according to the manufacturer’s instructions. SNPs were
analyzed using Illumina Beadstation 500GX, and geno-
types were analyzed using BeadStudio v.3 (Illumina, San
Diego, CA). For each SNP, 8.5 % of the total samples were
run in duplicate, and 100 % concordance was observed be-
tween duplicates. A genotyping success rate ranging from
79 % to 99 % was obtained for the SNPs under investiga-
tion (Additional file 1: Table S3).
Statistics
For the GWLS, model-free multipoint linkage analysis
was performed using Merlin, and allele frequencies were
estimated from all genotyped individuals [36]. Three
models were used for the statistical calculations. In dis-
ease model 1, individuals with T1D were set as affected.
In disease model 2, individuals with T1D, individuals
with AITD and individuals with both diseases were set
as affected. In disease model 3, individuals with AITD
were set as affected. Association analysis in the family-
based material was performed using FBAT v2.0.4Q
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(http://www.hsph.harvard.edu/fbat/default.html), which
is a software package used for computing Family Based
tests of Association. P-values were not corrected for
multiple comparisons. A SNP with a p-value <0.05 was
considered associated to T1D/AITD. The distribution of
alleles in the SNPs under investigation did not deviate
significantly from Hardy-Weinberg equilibrium in the
control group.
Results
In the first family recruitment, 42 families were identi-
fied, and 184 individual samples (54 patients with T1D,
48 patients with AITD, 12 patients with both disorders
and 70 unaffected family members) were collected to be
included in a 10-cM GWLS. The initial linkage analysis
revealed allele-sharing LOD scores > 1.5 (arbitrary
chosen cut-off ) at three locations: 1q23 (LOD = 1.99 at
marker D1S452), 4q26 (LOD = 1.92 at marker D4S402)
and 6p21 (LOD = 1.78 at marker D6S1549) (Fig. 1). Fine
mapping of the three regions of interest and the addition
of 275 individuals (69 patients with T1D, 62 patients
with AITD, 8 patients with both disorders and 136
unaffected family members) from 55 new families
increased the LOD score at 4q25 (LOD = 1.97 at marker
D4S1616) and 6p22 (LOD = 3.26 at marker D6S422) and
decreased the LOD score slightly at 1q23 (LOD = 1.77 at
marker D1S484) (Fig. 2).
SNPs chosen for the association study were selected
based on the results from our GWLS in combination
with SNPs associated to T1D/AITD in previously pub-
lished GWA studies [19–23]. 79 SNPs, 42 previously
published associated SNPs and 37 SNPs within the novel
susceptibility gene, CD247, were selected to be included
on an Illumina GoldenGate Custom Panel (Additional
file 1: Table S3). DNA from 459 individuals, including
123 patients with T1D, 110 patients with AITD, 20
patients with both disorders and 206 healthy individuals
from 97 families, were genotyped using this panel. SNPs
were tested for deviation from Hardy-Weinberg equilib-
rium in the control group using Haploview 3.2 [37]. Of the
79 SNPs included in the panel, 13 were associated (nom-
inal p < 0.05) with T1D, while 6 were associated with AITD
(nominal p < 0.05) (Table 1). Evidence in favor of associ-
ation with T1D was obtained for SNPs in PTPN22
(rs6679677 p = 4.5 × 10-4, rs2476601 p = 4.5 × 10-4), CD247
(rs6668182 p = 0.007, rs2988276 p = 3.8 × 10-5, rs7523351
p = 0.012, rs10918695 p = 0.006, rs12144621 p = 0.036,
rs863455 p = 0.025, rs704852 p = 0.029), HLA-DRB1
Fig. 1 Genome-wide multipoint allele-sharing LOD scores. The initial 10-cM GWLS was performed in 184 individuals from 42 families. The vertical
axis denotes the LOD scores, and the horizontal axis denotes the relative cM position on each chromosome (chr) (Genethon Map). Solid line, disease
model 1; dotted line, disease model 2; dashed line, disease model 3
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(rs9270986 p = 1.8x10-6) and INS (rs1004446 p = 0.011,
rs6356 p = 0.020, rs7111341 p = 0.021). Evidence in favor
of association with AITD was obtained for SNPs in
CD247 (rs17534481 p = 0.018, rs12095738 p = 0.022),
IFIH1 (rs1990760 p = 0.032), CTLA4 (rs3087243 p =
0.039), INS (rs6356 p = 0.014) and C12orf30
(rs17696736 p = 0.032). P-values were not corrected for
multiple testing.
Discussion
A GWLS and an association study was performed to
replicate known T1D/AITD susceptibility loci/variations
and to screen for novel loci in a multiplex family panel,
which included family members affected by T1D and/or
AITD, from northern Sweden. The AITD patient mater-
ial in this study included both Graves’ disease (GD) and
Hashimoto’s thyroid (HT) disease patients. Due to the
aim of this study we did not attempted to analyze HT
and GD as separate groups limiting the analysis to sig-
nals common to the two main groups included in the
AITD group.
The initial linkage analysis revealed a LOD score > 1.5 in
three regions on chromosomes 1q23, 4q25 and 6p21. The
one-lod-drop region on chromosome 4 (4q23-4q27) har-
bors 264 genes (http://www.ncbi.nlm.nih.gov/projects/
mapview) including the previously published susceptibility
genes IL2/IL21 [23, 38]. The one- lod-drop region on
chromosome 6 (6p24-6p12) contains 1247 genes including
the HLA genes and the one-lod-drop region on chromo-
some 1 (1q13-1q25) harbors 1378 genes including one
very interesting novel candidate gene, CD247.
Next we performed an association analysis to replicate
previously published associations as well as to elucidate
if there was an association between variants in CD247
and T1D/AITD. The follow-up association analysis con-
firmed associations with T1D for variants in PTPN22,
CD247, HLA and INS and associations with AITD for
variants in CD247, IFIH1, CTLA4, INS and C12orf30
with nominal p-values < 0.05. P-values were not cor-
rected for multiple testing. As expected, the most robust
evidence of association was found for SNPs at the HLA-
Fig. 2 Multipoint allele-sharing LOD scores after fine mapping. Multipoint allele-sharing LOD scores after fine mapping of regions with an LOD
score > 1.5 in the initial 10-cM GWLS and with the addition of 275 new individuals. The vertical axis denotes LOD scores, and the horizontal axis
denotes relative cM position (Genethon map). Genetic location of genes included in the association study is shown on the horizontal axis. Solid
line, disease model 1; dotted line, disease model 2; dashed line, disease model 3
Table 1 SNPs showing association to TID or AITD in the family
material from northern Sweden
Disease Chr SNP Gene p-value
T1D 1p13 rs6679677 PTPN22 4.5x10-4
T1D 1p13 rs2476601 PTPN22 4.5x10-4
T1D 1q24 rs6668182 CD247 0.007
T1D 1q24 rs2988276 CD247 3.8x10-5
T1D 1q24 rs7523351 CD247 0.012
T1D 1q24 rs10918695 CD247 0.006
T1D 1q24 rs12144621 CD247 0.036
T1D 1q24 rs863455 CD247 0.025
T1D 1q24 rs704852 CD247 0.029
T1D 6p21 rs9270986 HLA-DRB1 1.8x10-6
T1D 11p15 rs1004446 INS 0.011
T1D 11p15 rs6356 INS 0.020
T1D 11p15 rs7111341 INS 0.021
AITD 1q24 rs17534481 CD247 0.018
AITD 1q24 rs12095738 CD247 0.022
AITD 2q24 rs1990760 IFIH1 0.032
AITD 2q33 rs3087243 CTLA4 0.039
AITD 11p15 rs6356 INS 0.014
AITD 12q24 rs17696736 C12orf30 0.032
An association (p-value < 0.05) was found for 19 of the 79 SNPs on the
GoldenGate Custom Panel with T1D or AITD using the family based
association test (FBAT) (http://www.hsph.harvard.edu/fbat/default.html).
P-values were not corrected for multiple testing
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DRB1 locus on chromosome 6, with rs9270986
displaying the lowest p-value (p = 1.8x10-6). After this
association, the most robust evidence in favor of associ-
ation was unexpectedly observed for rs2988276 in
CD247 on chromosome 1 (p = 3.8 × 10-5).
Variants in PTPN22, HLA-DRB1, INS, IFIH1, CTLA4
and C12orf30 have previously been associated with T1D
[21, 23, 24, 33] and variants in most of the above genes
have been associated to AITD [4, 14, 34, 39–42] and
several other disorders [43–48]. No previous study has
shown association between T1D/AITD and CD247, but
variants in the gene have been associated with systemic
lupus erythematosus (SLE) [49–52], rheumatoid arthritis
(RA) [53] and systemic sclerosis [54].
CD247 codes for CD3ζ, which is a component of the
TCR/CD3 signaling complex on T cells, and tyrosine
phosphorylation of CD3ζ is one of the first events occur-
ring after TCR engagement [27, 28]. The CD3ζ subunit
functions as an amplifier of TCR signaling and is also
essential for efficient surface expression of the TCR/CD3
complex [55, 56]. Upon TCR engagement, CD8/CD4
delivers Lck to the CD3 complex, which leads to phos-
phorylation of ITAMs on CD3ζ. Phosphorylated CD3ζ
acts as a docking site for Zap-70, which in turn, leads to
the phosphorylation of Zap-70. Phosphorylated Zap-70
phosphorylates LAT, leading to downstream signaling
(reviewed in [57]). ITAM-mediated signal amplification
has been implicated as an important factor in the selection
of the mature T-cell repertoire. Positive and negative
selection in the thymus is impaired in CD3ζ-deficient mice
reconstituted with transgenes encoding CD3ζ with mu-
tated ITAMs. The requirement for ITAM-mediated signal
amplification is most evident in the positive selection of T
cells showing weak TCR-ligand interactions (reviewed in
[58]). Holst et al. demonstrated that mice with reduced
ITAMs in the TCR/CD3 complex develop a multi-organ
autoimmune disease caused by a breakdown in central
tolerance [59].
We have previously identified Cd247 as a candidate
susceptibility gene in murine T1D [60, 61] and we found
that the NOD allele of Cd247 confers impaired T cell
activation, resulting in altered cytokine expression pat-
terns, reduced proliferation and deficient CTLA-4
expression compared to the C57BL/6 (B6) allele of
Cd247 [60]. Altered expression and function of CD3ζ
has also been implicated in autoimmune disorders, such
as SLE [49, 62] and RA [63]. We did not find any associ-
ation between T1D/AITD and variants in IL2/IL21
despite the linkage peak observed in the 4q27 region.
One possible explanation for this is that the linkage to
T1D/AITD found in the region is caused by other genes
or variants than the ones used in our association study.
One limitation of the current study is the relative
modest size of the family-based materials employed.
Genome-wide associations can be due to spurious
causes, especially heterogeneity/population stratification.
Conclusion
The fact that we have found association to T1D/AITD
for five (PTPN22, IFIH1, CTLA4, INS and C12orf30)
previously reported non-HLA genes as well as a novel
susceptibility gene, CD247, supports the role for family-
based studies in the search for genes involved in com-
plex diseases. The results underpin the notion that the
population of northern Sweden is well suited to the
detection of genes involved in complex diseases. The use
of our more restricted patient material, compared to
other materials used in published GWA studies, enables
the discovery of disease associated genes in a more cost
effective manner and shows that our population is cap-
able of detecting general susceptibility genes. The access
to a genotyped family material with both affected and
non-affected family members will be very important for
future functional studies of associated gene variants.
Additional file
Additional file 1: Table S1. Clinical characteristics of the study material.
Table S2. HLA-DQB1 genotypes in the study material. Table S3. SNPs
included in the GoldenGate Custom Panel. (PDF 338 kb)
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